MacroGenics Inc (NASDAQ: MGNX) stock closed at $17.43 on 3/8/24 after a major decline of -15.0%. Moreover, trading volume in this decline was exceptionally high at 324% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -2.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, MGNX is expected to continue to be a major Value Builder.
MacroGenics has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. MacroGenics has a poor Appreciation Score of 27 but a very high Power Rating of 91, with the High Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment